Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells

Fig. 6

Localization of FUS in prostate cancer cells upon platinum drug treatments. Immunofluorescence staining of FUS and Coilin the localization response to 24 h drug treatments in the nuclei of A LNCaP, B PC-3, and C 22Rv1 cells. FUS (green), Coilin (red), merge of FUS and Coilin (Merge RG), brightfield, DAPI, and Merge of FUS, Coilin and DAPI is shown. Scale bars, 5 µm

Back to article page